Ly6Chigh monocytes protect against kidney damage during sepsis via a CX3CR1-dependent adhesion mechanism

Journal of the American Society of Nephrology

Volumn 27, Issue 3, 2016, Pages 792-803

  Chousterman, Benjamin G ^a,b,c,d   Boissonnas, Alexandre ^a,b,c   Poupel, Lucie ^a,b,c   De Chanville, Camille Baudesson ^a,b,c   Adam, Julien ^d   Tabibzadeh, Nahid ^a,e   Licata, Fabrice ^a,b,c   Lukaszewicz, Anne Claire ^b,f   Lombès, Amélie ^a,b,c   Deterre, Philippe ^a,b,c   Payen, DIdier ^b,f   Combadière, Christophe ^a,b,c  

^a SORBONNE UNIVERSITÉ   (France)

^b INSERM   (France)

^c CNRS   (France)

^d HÔPITAL LARIBOISIÈRE   (France)

^e INSTITUT GUSTAVE ROUSSY   (France)

^f HÔPITAL TENON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CX3CR1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 6; RED FLUORESCENT PROTEIN; CHEMOKINE RECEPTOR; CX3CR1 PROTEIN, HUMAN; CX3CR1 PROTEIN, MOUSE; INTERLEUKIN 1 RECEPTOR; LY ANTIGEN; LY-6C ANTIGEN, MOUSE;

ACUTE KIDNEY FAILURE; ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CLOTTING DISORDER; BLOOD VESSEL WALL; BONE MARROW CELL; CELL ADHESION; CELL ADHESION ASSAY; CELL MOTILITY; CELLULAR DISTRIBUTION; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DISEASE SEVERITY; FLOW CYTOMETRY; GENOTYPE; HUMAN; HUMAN CELL; IN VITRO STUDY; INTRAVITAL MICROSCOPY; KIDNEY INJURY; MAJOR CLINICAL STUDY; MALE; MONOCYTE; MONOCYTOPENIA; MOUSE; NEPHRITIS; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PERITONITIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY FAILURE; RESPIRATORY TRACT INFECTION; RETROSPECTIVE STUDY; SEPSIS; SHAM PROCEDURE; SURVIVAL; TIME LAPSE IMAGING; ACUTE KIDNEY INJURY; ACUTE PHASE RESPONSE; ALLELE; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; CELL MOTION; CHEMISTRY; COMPLICATION; GENETIC POLYMORPHISM; GENETICS; IMMUNOLOGY; METABOLISM; MULTIPHOTON MICROSCOPY; PATHOLOGY; PHYSIOLOGY; TRANSPLANTATION; VASCULAR ENDOTHELIUM;

ACUTE KIDNEY INJURY; ACUTE-PHASE REACTION; ADOPTIVE TRANSFER; ALLELES; ANIMALS; ANTIGENS, LY; CELL ADHESION; CELL MOVEMENT; ENDOTHELIUM, VASCULAR; GENOTYPE; HUMANS; INTRAVITAL MICROSCOPY; MALE; MICE; MICE, INBRED C57BL; MICROSCOPY, FLUORESCENCE, MULTIPHOTON; MONOCYTES; POLYMORPHISM, GENETIC; RECEPTORS, CHEMOKINE; RECEPTORS, INTERLEUKIN-1; SEPSIS;

EID: 84959912586     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2015010009     Document Type: Article

References (55)

1. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ; The ACCP/SCCMConsensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 101: 1644-1655, 1992
2. Angus DC, Linde-ZwirbleWT, LiDicker J, Clermont G, Carcillo J, Pinsky MR: Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med 29: 1303-1310, 2001
3. Vincent JL, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, Gerlach H, Moreno R, Carlet J, Le Gall JR, Payen D; SepsisOccurrence in Acutely Ill Patients Investigators: Sepsis in European intensive care units: Results of the SOAP study. Crit Care Med 34: 344-353, 2006
4. Angus DC, van der Poll T: Severe sepsis and septic shock. NEngl J Med 369: 840-851, 2013
5. Cohen J: The immunopathogenesis of sepsis. Nature 420: 885-891, 2002
6. Arnold L, Henry A, Poron F, Baba-Amer Y, van Rooijen N, Plonquet A, Gherardi RK, Chazaud B: Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis. J ExpMed 204: 1057-1069, 2007
7. Frantz S, Hofmann U, Fraccarollo D, Schäfer A, Kranepuhl S, Hagedorn I, Nieswandt B,NahrendorfM,Wagner H, Bayer B, Pachel C, SchönMP, Kneitz S, Bobinger T, Weidemann F, Ertl G, Bauersachs J: Monocytes/ macrophages prevent healing defects and left ventricular thrombus formation after myocardial infarction. FASEB J 27: 871-881, 2013
8. Grainger JR,Wohlfert EA, Fuss IJ, BouladouxN, AskenaseMH, Legrand F, Koo LY, Brenchley JM, Fraser ID, Belkaid Y: Inflammatory monocytes regulate pathologic responses to commensals during acute gastrointestinal infection. Nat Med 19: 713-721, 2013
9. Herold S, Tabar TS, JanssenH,Hoegner K, CabanskiM, Lewe-Schlosser P, Albrecht J, Driever F, Vadasz I, SeegerW, SteinmuellerM, Lohmeyer J: Exudate macrophages attenuate lung injury by the release of IL-1 receptor antagonist in gram-negative pneumonia. Am J Respir Crit Care Med 183: 1380-1390, 2011
10. Nahrendorf M, Swirski FK, Aikawa E, Stangenberg L, Wurdinger T, Figueiredo JL, Libby P, Weissleder R, Pittet MJ: The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J ExpMed 204: 3037-3047, 2007
11. Auffray C, Fogg D, Garfa M, Elain G, Join-Lambert O, Kayal S, Sarnacki S, Cumano A, Lauvau G, Geissmann F:Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior. Science 317: 666-670, 2007
12. Arend WP, Malyak M, Guthridge CJ, Gabay C: Interleukin-1 receptor antagonist: Role in biology. Annu Rev Immunol 16: 27-55, 1998
13. Remick DG, Call DR, Ebong SJ, Newcomb DE, Nybom P, Nemzek JA, Bolgos GE: Combination immunotherapy with soluble tumor necrosis factor receptors plus interleukin 1 receptor antagonist decreases sepsis mortality. Crit Care Med 29: 473-481, 2001
14. Lerolle N, Nochy D, Guérot E, Bruneval P, Fagon JY, Diehl JL, Hill G: Histopathology of septic shock induced acute kidney injury: Apoptosis and leukocytic infiltration. Intensive Care Med 36: 471-478, 2010
15. Schrier RW,Wang W: Acute renal failure and sepsis. NEngl JMed 351: 159-169, 2004
16. Raspé C, Höcherl K, Rath S, Sauvant C, Bucher M: NF-kB-mediated inverse regulation of fractalkine and CX3CR1 during CLP-induced sepsis. Cytokine 61: 97-103, 2013
17. Rittirsch D, Huber-Lang MS, Flierl MA, Ward PA: Immunodesign of experimental sepsis by cecal ligation and puncture. Nat Protoc 4: 31-36, 2009
18. John R, Nelson PJ: Dendritic cells in the kidney. J Am Soc Nephrol 18: 2628-2635, 2007
19. Schraml BU, van Blijswijk J, Zelenay S, Whitney PG, Filby A, Acton SE, Rogers NC,Moncaut N, Carvajal JJ, Reis e Sousa C: Genetic tracing via DNGR-1 expression history defines dendritic cells as a hematopoietic lineage. Cell 154: 843-858, 2013
20. Ovchinnikov DA, van Zuylen WJ, DeBats CE, Alexander KA, Kellie S, Hume DA: Expression of Gal4-dependent transgenes in cells of the mononuclear phagocyte system labeled with enhanced cyan fluorescent protein using Csf1r-Gal4VP16/UAS-ECFP double-transgenic mice. J Leukoc Biol 83: 430-433, 2008
21. Sauter KA, Pridans C, Sehgal A, Bain CC, Scott C, Moffat L, Rojo R, Stutchfield BM, Davies CL, Donaldson DS, Renault K, McColl BW, Mowat AM, Serrels A, Frame MC, Mabbott NA, Hume DA: The MacBlue binary transgene (csf1r-gal4VP16/UAS-ECFP) provides a novel marker for visualisation of subsets of monocytes, macrophages and dendritic cells and responsiveness to CSF1 administration. PLoS ONE 9: e105429, 2014
22. Soos TJ, Sims TN, Barisoni L, Lin K, Littman DR, Dustin ML, Nelson PJ: CX3CR1+ interstitial dendritic cells form a contiguous network throughout the entire kidney. Kidney Int 70: 591-596, 2006
23. Serbina NV, Pamer EG: Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2. Nat Immunol 7: 311-317, 2006
24. Ishida Y, Hayashi T, Goto T, Kimura A, Akimoto S, Mukaida N, Kondo T: Essential involvement of CX3CR1-mediated signals in the bactericidal host defense during septic peritonitis. J Immunol 181: 4208-4218, 2008
25. Vincent JL,Moreno R, Takala J,Willatts S, DeMendonça A, Bruining H, Reinhart CK, Suter PM, Thijs LG: The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 22: 707-710, 1996
26. Hochheiser K, Heuser C, Krause TA, Teteris S, Ilias A, Weisheit C, Hoss F, Tittel AP, Knolle PA, Panzer U, Engel DR, Tharaux PL, Kurts C: Exclusive CX3CR1 dependence of kidney DCs impacts glomerulonephritis progression. J Clin Invest 123: 4242-4254, 2013
27. Lionakis MS, Swamydas M, Fischer BG, Plantinga TS, Johnson MD, Jaeger M, Green NM, Masedunskas A, Weigert R, Mikelis C, Wan W, Lee CC, Lim JK, Rivollier A, Yang JC, Laird GM,Wheeler RT, Alexander BD, Perfect JR, Gao JL, Kullberg BJ, Netea MG, Murphy PM: CX3CR1-dependent renal macrophage survival promotes Candida control and host survival. J Clin Invest 123: 5035-5051, 2013
28. Dorgham K, Ghadiri A, Hermand P, RoderoM, Poupel L, IgaM, Hartley O, Gorochov G, Combadière C, Deterre P: An engineered CX3CR1 antagonist endowed with anti-inflammatory activity. J Leukoc Biol 86: 903-911, 2009
29. Lavergne E, Labreuche J, Daoudi M, Debré P, Cambien F, Deterre P, Amarenco P, Combadière C; GENIC Investigators: Adverse associations between CX3CR1 polymorphisms and risk of cardiovascular or cerebrovascular disease. Arterioscler Thromb Vasc Biol 25: 847-853, 2005
30. Moatti D, Faure S, Fumeron F,AmaraM-W, Seknadji P,McDermottDH, Debré P, Aumont MC, Murphy PM, de Prost D, Combadière C: Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease. Blood 97: 1925-1928, 2001
31. McDermott DH, Halcox JP, Schenke WH, Waclawiw MA, Merrell MN, EpsteinN,QuyyumiAA,Murphy PM: Associationbetween polymorphism in the chemokine receptor CX3CR1 and coronary vascular endothelial dysfunction and atherosclerosis. Circ Res 89: 401-407, 2001
32. Rodero M, Marie Y, Coudert M, Blondet E, Mokhtari K, Rousseau A, Raoul W, Carpentier C, Sennlaub F, Deterre P, Delattre JY, Debré P, Sanson M, Combadière C: Polymorphism in the microglial cellmobilizing CX3CR1 gene is associated with survival in patients with glioblastoma. J Clin Oncol 26: 5957-5964, 2008
33. Sirois-Gagnon D, Chamberland A, Perron S, Brisson D, Gaudet D, Laprise C: Association of common polymorphisms in the fractalkine receptor (CX3CR1) with obesity. Obesity (Silver Spring) 19: 222-227, 2011
34. Daoudi M, Lavergne E, Garin A, Tarantino N, Debré P, Pincet F, Combadière C, Deterre P: Enhanced adhesive capacities of the naturally occurring Ile249-Met280 variant of the chemokine receptor CX3CR1. J Biol Chem 279: 19649-19657, 2004
35. Aird WC: The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood 101: 3765-3777, 2003
36. Cavaillon JM, Adib-Conquy M: Monocytes/macrophages and sepsis. Crit Care Med 33[Suppl]: S506-S509, 2005
37. Serbina NV, Jia T, Hohl TM, Pamer EG: Monocyte-mediated defense against microbial pathogens. Annu Rev Immunol 26: 421-452, 2008
38. Winter C, Taut K, Srivastava M, Länger F, Mack M, Briles DE, Paton JC, Maus R,Welte T, Gunn MD, Maus UA: Lung-specific overexpression of CC chemokine ligand (CCL) 2 enhances the host defense to Streptococcus pneumoniae infection in mice: Role of the CCL2-CCR2 axis. J Immunol 178: 5828-5838, 2007
39. Chen L, Zhang Z, Barletta KE, BurdickMD,Mehrad B: Heterogeneity of lung mononuclear phagocytes during pneumonia: Contribution of chemokine receptors. Am J Physiol Lung Cell Mol Physiol 305: L702-L711, 2013
40. Seeley EJ, Barry SS, Narala S, Matthay MA, Wolters PJ: Noradrenergic neurons regulate monocyte trafficking and mortality during gramnegative peritonitis in mice. J Immunol 190: 4717-4724, 2013
41. Winter C, Herbold W, Maus R, Länger F, Briles DE, Paton JC, Welte T, Maus UA: Important role for CC chemokine ligand 2-dependent lung mononuclear phagocyte recruitment to inhibit sepsis in mice infected with Streptococcus pneumoniae. J Immunol 182: 4931-4937, 2009
42. Dunay IR, Damatta RA, Fux B, Presti R, Greco S, Colonna M, Sibley LD: Gr1(+) inflammatory monocytes are required for mucosal resistance to the pathogen Toxoplasma gondii. Immunity 29: 306-317, 2008
43. Carlin LM, Stamatiades EG, Auffray C, Hanna RN, Glover L, Vizcay-Barrena G, HedrickCC,CookHT,Diebold S, Geissmann F:Nr4a1-dependent Ly6C (low) monocytes monitor endothelial cells and orchestrate their disposal. Cell 153: 362-375, 2013
44. Bazan JF, Bacon KB,HardimanG,WangW, Soo K, Rossi D,GreavesDR, Zlotnik A, Schall TJ: A new class ofmembrane-bound chemokine with a CX3C motif. Nature 385: 640-644, 1997
45. Harrison JK, Jiang Y, Wees EA, Salafranca MN, Liang HX, Feng L, Belardinelli L: Inflammatory agents regulate in vivo expression of fractalkine in endothelial cells of the rat heart. J Leukoc Biol 66: 937-944, 1999
46. He M, Moochhala SM, Adhikari S, Bhatia M: Administration of exogenous fractalkine, a CX3C chemokine, is capable of modulating inflammatory response in cecal ligation and puncture-induced sepsis. Shock 31: 33-39, 2009
47. Goda S, Imai T, Yoshie O, Yoneda O, Inoue H, Nagano Y, Okazaki T, Imai H, Bloom ET, Domae N, Umehara H: CX3C-chemokine, fractalkine-enhanced adhesion of THP-1 cells to endothelial cells through integrin-dependent and-independent mechanisms. J Immunol 164: 4313-4320, 2000
48. Kerfoot SM, Lord SE, Bell RB, Gill V, Robbins SM, Kubes P: Human fractalkine mediates leukocyte adhesion but not capture under physiological shear conditions; a mechanism for selective monocyte recruitment. Eur J Immunol 33: 729-739, 2003
49. Wang Y, Roller J, Menger MD, Thorlacius H: Sepsis-induced leukocyte adhesion in the pulmonary microvasculature in vivo is mediated by CD11a and CD11b. Eur J Pharmacol 702: 135-141, 2013
50. Petit-Bertron AF, Fitting C, Cavaillon JM, Adib-Conquy M: Adherence influences monocyte responsiveness to interleukin-10. J Leukoc Biol 73: 145-154, 2003
51. Yurochko AD, Liu DY, Eierman D, Haskill S: Integrins as a primary signal transduction molecule regulating monocyte immediate-early gene induction. Proc Natl Acad Sci U S A 89: 9034-9038, 1992
52. Zarbock A, Gomez H, Kellum JA: Sepsis-induced acute kidney injury revisited: pathophysiology, prevention and future therapies. Curr Opin Crit Care 20: 588-595, 2014
53. Saederup N, Cardona AE, Croft K, Mizutani M, Cotleur AC, Tsou CL, Ransohoff RM, Charo IF: Selective chemokine receptor usage by central nervous system myeloid cells in CCR2-red fluorescent protein knock-in mice. PLoS ONE 5: e13693, 2010
54. Combadière C, Potteaux S, Gao JL, Esposito B, Casanova S, Lee EJ, Debré P, Tedgui A, Murphy PM, Mallat Z: Decreased atherosclerotic lesion formation in CX3CR1/apolipoprotein E double knockout mice. Circulation 107: 1009-1016, 2003
55. Payen D, Lukaszewicz AC, LegrandM, Gayat E, Faivre V,Megarbane B, Azoulay E, Fieux F,CharronD, Loiseau P, BussonM:Amulticentre study of acute kidney injury in severe sepsis and septic shock: Association with inflammatory phenotype and HLA genotype. PLoS ONE 7: e35838, 2012